| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $774,475 | 19 | 100 |
Sells | $0 | 0 | 0 |
| Opaleye Management Inc. | 10 percent owner | 18 | $560,475 | 0 | $0 | $560,475 |
| Kohli Prashant | Chief Executive Officer | 1 | $214,000 | 0 | $0 | $214,000 |
Grace Therapeutics, Inc. specializes in the creation and commercialization of pharmaceutical products, primarily targeting uncommon and neglected diseases, with operations centered in Canada. The company's most advanced experimental treatment is GTX-104, an intravenous infusion designed to address subarachnoid hemorrhage. Its development pipeline further includes GTX-102, an oral mucosal betamethasone spray intended for the management of ataxia-telangiectasia, and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic …
Over the last 12 months, insiders at Grace Therapeutics, Inc. have bought $774,475 and sold $0 worth of Grace Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Grace Therapeutics, Inc. have bought $774,475 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Opaleye Management Inc. (10 percent owner) — $560,475. Kohli Prashant (Chief Executive Officer) — $214,000.
The last purchase of 66,411 shares for transaction amount of $117,408 was made by Opaleye Management Inc. (10 percent owner) on 2026‑10‑26.
| 2026-10-26 | Opaleye Management Inc. | 10 percent owner | 66,411 0.3756% | $1.77 | $117,408 | +5.25% | ||
| 2026-10-22 | Opaleye Management Inc. | 10 percent owner | 21,390 0.1242% | $1.93 | $41,193 | -0.78% | ||
| 2026-10-19 | Opaleye Management Inc. | 10 percent owner | 4,256 0.0262% | $1.88 | $8,001 | +2.66% | ||
| 2026-10-16 | Opaleye Management Inc. | 10 percent owner | 36,347 0.2235% | $1.89 | $68,758 | +1.72% | ||
| 2026-10-15 | Opaleye Management Inc. | 10 percent owner | 23,485 0.144% | $1.95 | $45,685 | -1.79% | ||
| 2026-10-14 | Opaleye Management Inc. | 10 percent owner | 11,233 0.0707% | $1.93 | $21,735 | +1.72% | ||
| 2026-10-12 | Opaleye Management Inc. | 10 percent owner | 7,215 0.0418% | $2.02 | $14,574 | -4.83% | ||
| 2026-10-09 | Opaleye Management Inc. | 10 percent owner | 5,340 0.0304% | $2.04 | $10,918 | -7.21% | ||
| 2026-10-08 | Opaleye Management Inc. | 10 percent owner | 2,077 0.0119% | $2.02 | $4,190 | -5.15% | ||
| 2026-10-05 | Opaleye Management Inc. | 10 percent owner | 1,694 0.0098% | $2.06 | $3,490 | -5.83% | ||
| 2026-10-02 | Opaleye Management Inc. | 10 percent owner | 20,000 0.1157% | $2.07 | $41,368 | -6.04% | ||
| 2026-10-01 | Opaleye Management Inc. | 10 percent owner | 38,796 0.2241% | $2.04 | $78,962 | -4.41% | ||
| 2026-09-29 | Opaleye Management Inc. | 10 percent owner | 7,849 0.0478% | $2.09 | $16,404 | -6.64% | ||
| 2026-09-23 | Opaleye Management Inc. | 10 percent owner | 5,318 0.0324% | $2.10 | $11,168 | -6.13% | ||
| 2026-09-21 | Opaleye Management Inc. | 10 percent owner | 9,771 0.0598% | $2.10 | $20,519 | -4.29% | ||
| 2026-09-09 | Opaleye Management Inc. | 10 percent owner | 5,836 0.035% | $2.09 | $12,197 | -3.74% | ||
| 2026-09-09 | Kohli Prashant | Chief Executive Officer | 100,000 0.6145% | $2.14 | $214,000 | -3.74% | ||
| 2026-09-08 | Opaleye Management Inc. | 10 percent owner | 9,393 0.0538% | $2.10 | $19,699 | -2.71% | ||
| 2026-08-14 | Opaleye Management Inc. | 10 percent owner | 11,608 0.0649% | $2.09 | $24,206 | -2.31% |
| Increased Positions | 13 | +68.42% | 869,177 | +23.45% |
| Decreased Positions | 5 | -26.32% | 247,795 | -6.69% |
| New Positions | 7 | New | 478,571 | New |
| Sold Out Positions | 4 | Sold Out | 247,767 | Sold Out |
| Total Postitions | 27 | +42.11% | 4M | +16.77% |